Focus 1:147-149 (2003)
© 2003 American Psychiatric Association
Bibliography for Substance-Related Disorders
 |
INTRODUCTION
|
|---|
This section of the journal contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. The entries for the bibliography are listed in reverse chronological order. Articles from the bibliography that are reprinted in this issue are in bold.
|
GENERAL
|
|---|
Mack A, Franklin JE, Frances RJ: Concise Guide to Treatment of Alcoholism and Addictions. Washington, DC, American Psychiatric Press, Inc, 2000
Medical Letter: Tests for drugs of abuse. Med Lett Drugs Ther 2002 44:71–73
Kelly RH, Zatzick DF, Anders TF: The detection and treatment of psychiatric disorders and substance use among pregnant women cared for in obstetrics. Am J Psychiatry 2001; 158:213–219
McLellan AT, Lewis DC, O’Brien CP, Kleber HD: Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284:1689–1695
Galanter M, Kleber HD: American Psychiatric Press Textbook of Substance Abuse Treatment, 2nd ed. Washington, DC, American Psychiatric Press, Inc, 1999
Leshner AI: Science is revolutionizing our view of addiction—and what to do about it. Am J Psychiatry 1999; 156:1–3
Meyers RJ, Miller WR, Hill DE, Tonigan JS: Community reinforcement and family training (CRAFT): engaging unmotivated drug users into treatment. J Subst Abuse 1999; 10:291–308
Leshner AI, Koob GF: Drugs of abuse and the brain. Proc Assoc Am Physicians 1999; 111:99–108
Franklin J: Minority populations, in Clinical Textbook of Addictive Disorders, 2nd ed. Edited by Frances RJ, Miller SI. New York, Guilford, 1998
Leshner AI: Addiction is a brain disease and it matters. Science 1997; 278:45–47
McLellan AT, Grissom GR, Zanis D, Randall M, Brill P, O’Brien CP: Problem-service matching in addiction treatment: a prospective study in 4 programs. Arch Gen Psychiatry 1997; 54:730–735
Thompson J, Walker RD, Silk-Walker P: Mental disorders in American Indians and Alaska Natives, in Textbook of Cross-Cultural Psychiatry. Edited by Gaw A. Washington, DC, American Psychiatric Press, 1993, pp 189–243
|
GENERAL—COMORBIDITY
|
|---|
Cacciola JS, Alterman AI, McKay JR, Rutherford MJ: Psychiatric comorbidity in patients with substance use disorders: do not forget axis II disorders. Psychiatric Annals 2001; 31:321–331
Clodfelter RC Jr, McDowell DM: Bipolar disorder and substance abuse: considerations of etiology, comorbidity, evaluation, and treatment. Psychiatric Annals 2001; 31:294–299
Galanter M: Self-help treatment for combined addiction and mental illness. Psychiatr Serv 2000; 51:977–979
Strakowski SM, DelBello MP, Fleck DE, Arndt S: The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry 2000; 48:477–485
Linehan MM, Schmidt H III, Dimeff LA, Craft JC, Kanter J, Comtois KA: Dialectical behavior therapy for patients with borderline personality disorder and drug dependence. Am J Addict 1999; 8:279–292
Institute of Medicine: Workshop Summary: The Role of Co-occurring Substance Abuse and Mental Illness in Violence. Institute of Medicine, Division of Neuroscience and Behavioral Health. Washington, DC, National Academy Press, 1999
Schuckit MA, Tipp JE, Bergman M, Reich W, Hesselbrock VM, Smith TL: Comparison of induced and independent major depressive disorders in 2,945 alcoholics. Am J Psychiatry 1997; 154:948–957
Lehman AF, Myers CP, Thompson JW, Corty E: Implications of mental and substance use disorders: A comparison of "single" and "dual" diagnosis patients. J Nerv Ment Dis 1993; 181:365–370
Prochaska JO, DiClemente CC, Norcross JC: In search of how people change: applications to addictive behavior. Am Psychol 1992; 47:1102–1114
Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK: Co-morbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area study. JAMA 1990; 264:2511–2518
|
GENERAL—ADOLESCENT
|
|---|
Hser Y-I, Grella CE, Hubbard RL, Hsieh SC, Fletcher BW, Brown BS, Anglin MD: An evaluation of drug treatments for adolescents in 4 US cities. Arch Gen Psychiatry 2001; 58:689–695
Johnston LD, O’Malley PM, Bachman JG: Monitoring the Future: National Survey Results on Adolescent Drug Use: Overview of Key Findings, 2000. NIH Publ No 01-4923. Bethesda, MD, National Institute on Drug Abuse, 2001
Kaminer Y: Contingency management reinforcement procedures for adolescent substance abuse. J Am Acad Child Adolesc Psychiatry 2000; 39:1324–1326
Treatment of adolescents with substance use disorders. TIPS 32. Rockville, MD, Center for Substance Abuse Treatment, 1999
Geller B, Cooper T, Sun K, Zimerman B, Frazier J, Williams M, Heath J: Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 1998; 37:171–178
Weinberg NZ, Rahdert E, Colliver JD, Glantz MD: Adolescent substance abuse: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1998; 37:252–261
American Academy of Child and Adolescent Psychiatry: Practice Parameters for the assessment and treatment of children and adolescents with substance use disorders. J Am Acad Child Adolesc Psychiatry 1997; 36(10 suppl):140S–156S
Biederman J, Wilens T, Mick E, Faraone SV, Weber W, Curtis S, Thornell A, Pfister K, Jetton JG, Soriano J: Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1997; 36:21–29
Azrin NH, Donohue B, Besalel VA, McMahon P: Youth drug abuse treatment: a controlled outcome study. J Child Adolesc Subst Abuse 1994; 3:1–16
|
ALCOHOL
|
|---|
Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S: Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry 2002; 41:378–385
Shore J, Manson SM, Buchwald D: Screening for alcohol abuse among urban Native Americans in a primary care setting. Psychiatr Serv 2002; 53:757–760
Hommer DW, Momenan R, Kaiser E, Rawlings R: Evidence for a gender-related effect of alcoholism on brain volumes. Am J Psychiatry 2001; 158:198–204
Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA: Naltrexone in the treatment of alcohol dependence. N Engl J Med 2001; 345:1734–1739
Pettinati HM, Volpicelli JR, Luck G, Kranzler HR, Rukstalis MR, Cnaan A: Double-blind clinical trial of sertraline treatment of alcohol dependence. J Clin Psychopharmacol 2001; 21:143–153
Schuckit MA, Smith TL, Danko GP: Five-year clinical course associated with DSM-IV alcohol abuse or dependence in a large group of men and women. Am J Psychiatry 2001; 158:1084–1090
Singletary KW, Gapstur SM: Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 2001; 286:2143–2151
Jacobs EA, Copperman SM, Jeffe A, Kulig J: Fetal alcohol syndrome and alcohol-related neurodevelopmental disorders. Pediatrics 2000; 106:358–361
Anton RF, Moak DH, Waid LR, Malcolm RJ, Dias JK, Roberts JS: Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 1999; 156:1758–1764
Harwood H, Fountain D, Livermore G: The Economic Costs of Alcohol and Drug Abuse in the United States, 1992. Washington, DC, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, 1998
Schuckit MA, Smith TL, Daeppen JB, Eng M, Li TK, Hesselbrock VM, Nurnberger JI Jr, Bucholz KK: Clinical relevance of the distinction between alcohol dependence with and without a physiological component. Am J Psychiatry 1998; 155:733–740
Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC: Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997; 54:313–321
Project MATCH Research Group: Matching alcoholism treatments to client heterogeneity: Project MATCH post-treatment drinking outcomes. J Stud Alcohol 1997; 58:7–29
O’Malley SS, Jaffe AJ, Chang G, Rode S, Schottenfeld R, Meyer RE, Rounsaville B: Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry 1996; 53:217–224
Vaillant GE: A long-term follow-up of male alcohol abuse. Arch Gen Psychiatry 1996; 53:243–249
Armor DJ, Polish SM, Stambul HB: Alcoholics and Treatment. New York, Wiley, 1978
|
COCAINE
|
|---|
Simpson D, Joe GW, Broome KM: A national 5-year follow-up of treatment outcomes for cocaine dependence. Arch Gen Psychiatry 2002; 59:538–544
Singer LT, Arendt R, Minnes S, Farkas K, Salvator A, Kirchner HL, Kliegman R: Cognitive and motor outcomes of cocaine-exposed infants. JAMA 2002; 287:1952–1960
Kilts CD, Schweitzer JB, Quinn CK: Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry 2001; 58:334–341
Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken LS, Muenz LR, Thase ME, Weiss RD, Gastfriend DR, Woody GE, Barber JP, Butler SF, Daley D, Salloum I, Bishop S, Najavits LM, Lis J, Mercer D, Griffin ML, Moras K, Beck AT: Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry 1999; 56:493–502
Higgins ST, Budney SJ, Bickel WK, Foerg FE, Donham R, Badger GJ: Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry 1994; 51:568–576
|
CANNABIS, MDMA, AMPHETAMINES
|
|---|
Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, Christiansen K, McRee B, Vendetti J: Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002; 287:1123–1131
Bovasso GB: Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry 2001; 158:2033–2037
Reneman L, Lavalaye J, Schmand B: Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"): preliminary findings. Arch Gen Psychiatry 2001; 58:901–906
Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N: Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001; 158:2015–2021
Jonas MM, Graeme-Cook FM: A 17-year-old girl with marked jaundice and weight loss. N Engl J Med 2001; 344:591–599
Van Kampen J, Katz M: Persistent psychosis after a single ingestion of "ecstasy." Psychosomatics 2001; 42:525–527
McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA: Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet 1998; 352:1433–1437
Flaum M, Schultz SK: When does amphetamine-induced psychosis become schizophrenia? Am J Psychiatry 1996; 153:812–815
|
NICOTINE
|
|---|
Ahluwalia JS, Harris KJ, Catley D: Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. JAMA 2002; 288:468–474
Breslau N, Johnson EO, Hiripi E, Kessler R: Nicotine dependence in the United States: prevalence, trends, and smoking persistence. Arch Gen Psychiatry 2001; 58:810–816
|
OPIOIDS
|
|---|
Fiellin DA, O’Connon PG: Office-based treatment of opioid-dependent patients. N Engl J Med 2002; 347:817–823
Daglish MR, Weinstein A, Malizia AL, Wilson S, Melichar JK, Britten S, Brewer C, Lingford-Hughes A, Myles JS, Grasby P, Nutt DJ: Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects. Am J Psychiatry 2001; 158:1680–1686
Johnson RE, Chatuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE: A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med 2000; 343:1290–1297
Kreek MJ: Methadone-related opioid agonist pharmacotherapy for heroin addiction: history, recent molecular and neurochemical research, and future in mainstream medicine. Ann N Y Acad Sci 2000; 909:186–216
Sees KL, Delucci KL, Masson C, Rosen A, Clark HW, Robillard H, Banys P, Hall SM: Methadone maintenance versus 180-day psychosocially enriched detoxification for treatment of opioid dependence. JAMA 2000; 283:1303–1310
Brown HL, Britton KA, Mahaffey D, Brizendine E, Hiett AK, Turnquest MA: Methadone maintenance in pregnancy: a reappraisal. Am J Obstet Gynecol 1998; 179:459–463
Ling W, Charuvastra C, Collins JF, Batki S, Brown LS Jr, Kintaudi P, Wesson DR, McNicholas L, Tusel DJ, Malkerneker U, Renner JA Jr, Santos E, Casadonte P, Fye C, Stine S, Wang RI, Segal D: Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction 1998; 93:475–486
O’Connor PG, Carroll KM, Shi JM, Schottenfeld RS, Kosten TR, Rounsaville BJ: Three methods of opioid detoxification in a primary care setting: a randomized trial. Ann Intern Med 1997; 127:526–530
McLellan AT, Grissom GR, Zanis D, Randall M, Brill P, O’Brien CP: Problem-service matching in addiction treatment: a prospective study in 4 programs. Arch Gen Psychiatry 1997; 54:730–735
Volpicelli JR, Alterman AI, Hayashida M, O’Brien CP: Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992; 49:876–887
Get information about faster international access.
Privacy Policy
Copyright © 2003
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
TOP
Introduction
General
